Form 1-K — Nok Therapeutics, Inc.
0001213900-26-050128 · filed Apr 30, 2026
Offering
- Total offering
- —
- Total sold
- —
- Security type
- —
- Price per security
- —
- Over-allotment
- —
- Jurisdictions
- —
Issuer
- CIK
- 2038166
- Entity
- Corporation
- Jurisdiction
- FLORIDA
- Address
- 2009 MACKENZIE WAY
CRANBERRY TWP., PA 16066
Most recent fiscal year financials
Reg A+ Tier 2 financials are audited (1-A, 1-K). Tier 1 are reviewed.
- Total assets
- —
- Total liabilities
- —
- Cash
- —
- Total revenues
- —
- Net income
- —
Same issuer's Form D filings
View the original filing on SEC EDGAR ↗